Format

Send to

Choose Destination

See 1 citation found by title matching your search:

J Vasc Interv Radiol. 2016 Jun;27(6):846-51. doi: 10.1016/j.jvir.2016.01.148. Epub 2016 Apr 11.

Safety of Percutaneous Biopsy for Hepatic Angiosarcoma: Results of a Multicenter Korean Survey.

Author information

1
Department of Radiology Samsung Medical Center, Sungkyunkwan University School of Medicine; Seoul.
2
Department of Radiology Samsung Medical Center, Sungkyunkwan University School of Medicine; Seoul. Electronic address: leeminwoo0@gmail.com.
3
Department of Radiology, Yonsei Medical Center, Yonsei University School of Medicine; Seoul.
4
Seoul National University Hospital, Seoul National University College of Medicine; Seoul.
5
Department of Radiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul.
6
Department of Radiology, Hanyang University Guri Hospital, Hanyang University School of Medicine; Busan, Korea.
7
Department of Radiology, Kosin University Gospel Hospital, Kosin University School of Medicine, Busan, Korea.
8
Department of Radiology, Inje University Ilsan Paik Hospital, Inje University School of Medicine, Gyeonggi, Korea.
9
Biostatics and Clinical Epidemiology Center, Samsung Medical Center, Sungkyunkwan University School of Medicine; Seoul.

Abstract

PURPOSE:

To evaluate the incidence of severe bleeding and mortality associated with percutaneous biopsy for hepatic angiosarcoma in a multicenter retrospective cohort.

MATERIALS AND METHODS:

A retrospective review of 33 patients with biopsy-proven hepatic angiosarcoma (29 male; median age, 57 y; age range, 24-96 y) was performed at seven tertiary academic hospitals between January 1998 and March 2015. The mean maximum tumor size was 5.5 cm (range, 1.7-20 cm). An 18-gauge automated cutting biopsy needle was used with a freehand technique in all patients who underwent ultrasonography-guided percutaneous core needle biopsy on an inpatient basis. The incidences of severe bleeding and procedure-related mortality were evaluated per Society of Interventional Radiology (SIR) guidelines.

RESULTS:

There was a mean of 2.8 needle passes per patient during the procedure (range, 1-6). The overall incidence of severe bleeding events (SIR grade C/D) was 9.1% (3 of 33). Two patients were managed with blood transfusion, and one patient underwent embolization for bleeding control. No other major complications were encountered. There were no cases of mortality associated with the biopsy.

CONCLUSIONS:

Severe bleeding was not a frequent complication after percutaneous biopsy for hepatic angiosarcoma. The majority of bleeding complications could be controlled with conservative management.

PMID:
27080009
DOI:
10.1016/j.jvir.2016.01.148
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center